COLL vs GE · P/E 17, rev $181.9M vs P/E 44, rev $45.85B
Collegium Pharmaceutical Inc (COLL) versus GE Aerospace (GE) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported GE revenue for 2025-12-31 was $45.85B. Net income was $8.70B. Revenue was up 324.1% from 2024-12-31 to 2025-12-31. GE currently screens at market cap $373.04B and trailing P/E 44.4.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Not investment advice. Open the COLL and GE stock pages for the full models.
Not investment advice.